Catharina Hospital

Eindhoven 5632 EJ

2 studies enrolling now · 10 studies all time

What they study most

Acute Myocardial Infarction, Acute Myocardial Infarction (AMI), Antimetabolites, Antineoplastic, Chronic Obstructive Pulmonary Disease, Coronary Arteriosclerosis, Coronary Artery Disease (CAD), Digestive System Diseases, Digestive System Neoplasms, Early Breast Cancer, Endocrine Gland Neoplasms, Endocrine System Diseases, Gemcitabine

Studies at this site

• A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD) — Recruiting now
• Selatogrel Outcome Study in Suspected Acute Myocardial Infarction — Enrolling by invitation
• A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer) — Running, not enrolling
• Primary Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy (HIPEC) — Running, not enrolling
• Zephyrus II: Efficacy and Safety Study of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF) — Stopped early
• An International Study to Evaluate Diagnostic Efficacy of Flurpiridaz (18F) Injection PET MPI in the Detection of Coronary Artery Disease (CAD) — Completed
• Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the "Apact" Study) — Completed
• A PRospective, rAndomizEd Comparison of subcuTaneOous and tRansvenous ImplANtable Cardioverter Defibrillator Therapy — Status unconfirmed
• Fractional Flow Reserve Versus Angiography for Multivessel Evaluation (F.A.M.E.) — Completed
• Counterpulsation Reduces Infarct Size Pre-PCI for AMI — Completed